Background. Toll-like receptors (TLRs) play critical roles in innate immune response by sensing pathogen-or damage-associated molecular patterns. Epidermal keratinocytes and dermal fibroblasts also produce proinflammatory cytokines and chemokines under stimulation with TLR ligands. Serum amyloid A (SAA) is an essential factor in the pathogenesis of secondary amyloidosis, and also has immunomodulatory functions. SAA are produced mainly by hepatocytes but also by a variety of cells, including immune cells, endothelial cells, synoviocytes, and epidermal keratinocytes. However, SAA expression in human dermal fibroblasts has not been shown to date. Aim. To investigate the effect of TLR ligands on SAA expression in epidermal keratinocytes and dermal fibroblasts. Methods. We investigated whether TLR ligands induce the expression of SAA in normal human epidermal keratinocytes (NHEKs) and normal human dermal fibroblasts (NHDFs) by real-time quantitative PCR and ELISA. The effect of SAA on its own expression in NHDFs was also studied. Results. SAA expression was induced via nuclear factor-jB by TLR1/2, 3, 5 and 2/6 ligands in NHEKs. In NHDFs, TLR1/2 and TLR2/6 ligands increased SAA expression. SAA further induced its own expression via TLR1/2 and NF-jB in NHDFs, as previously reported for NHEKs. Conclusions. Our results provide new evidence that the skin's innate immune response contributes to the production of SAA, which might lead to an increased risk of systemic complications such as secondary amyloidosis of recessive dystrophic epidermolysis bullosa.
Introduction
The skin is the first line of defence against the external environment of the body. 1 Therefore, in the skin, the innate immune system, a nonspecific and rapid inflammatory reaction, is an essential defence, and it is comprised of numerous cell types, including keratinocytes, neutrophils and macrophages. 1 Skin inflammation following injury starts when Toll-like receptors (TLRs) in keratinocytes at the injured site(s) recognize molecules derived from microbes (pathogen-associated molecular patterns; PAMPs), or molecules derived from injured cells (damage-associated molecular patterns; DAMPs). [2] [3] [4] [5] PAMPs and DAMPs are also recognized by a number of receptors, including nucleotide oligomerization domain (NOD)-like receptors (NLRs), retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), receptor for advanced glycation end products (RAGE) and C-type lectin receptors. 6 In addition to keratinocytes, another type of resident structural cells, fibroblasts, also express TLRs, and can also produce proinflammatory cytokines and chemokines, the production of which triggers and enhances skin inflammation. 2 TLR signalling has been reported to induce proinflammatory cytokines through NF-jB. 7 Serum amyloid A (SAA) is a 12-kDa acute phage protein encoded by the genes SAA1-4, which are located on human chromosome 11.
8 SAA1 and SAA2 encode acute phage proteins, SAA3 is a pseudogene, and SAA4 is constitutively expressed. 8 SAA is induced by proinflammatory cytokines such as tumour necrosis factor-a and interleukin-6, synthesized mainly by the liver, and predominantly bound to high-density lipoprotein in the blood. 8 Secondary amyloidosis is a critical disease characterized by the extracellular tissue deposition of the insoluble amyloid fibrils derived from SAA, and it complicates any chronic inflammatory disease, including rheumatoid arthritis (RA). 9 The persistent high concentration of SAA in the sera is reported to be a prerequisite for the development of secondary amyloidosis. 10 SAA are produced not only by hepatocytes but also by a variety of cells, including immune cells, endothelial cells, and synoviocytes. 8 In addition, SAA is also considered to act as a DAMP molecule. 6 In RA, expression of SAA is increased in synoviocytes of the joints, and it is considered to act as an exacerbation factor of local inflammation because it has proinflammatory functions. 8, 11 Epidermal keratinocytes also express SAA, [12] [13] [14] but SAA expression in human dermal fibroblasts has not been reported to date.
Epidermolysis bullosa (EB) is an inherited blistering disorder of the skin and mucosal membranes, which is caused by mutations in keratin or collagen genes, and has various subtypes. 15 Recessive dystrophic epidermolysis bullosa (RDEB) is an uncommon and severe subtype of EB, characterized by inherently fragile skin and recurrent blister formation occurring over the whole body within weeks after birth, and caused by mutations in the type VII collagen gene COL7A1. 15 Patients with RDEB show persistent, widespread skin ulcers, and develop complications such as oesophageal stricture, infection, pseudosyndactyly, renal failure, cutaneous squamous cell carcinoma and secondary amyloidosis. 16, 17 Expression of SAA has previously been reported to be elevated in the sera of patients with RDEB. 18 In addition, we reported that such elevation is persistent in these patients. 19 However, the mechanism of the increase in SAA expression in patients with RDEB has not been shown to date.
SAA, a precursor of amyloid protein, potently activates immunocytes and induces proinflammatory cytokines and chemokines. 8 Previously, SAA was shown to induce IL-6 expression in dermal fibroblasts, 20 and we also reported that SAA induces the expression of SAA itself in epidermal keratinocytes.
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O'Reilly et al. showed that SAA induces interleukin (IL)-6 expression via TLR2 but not TLR4 in dermal fibroblasts. 20 In epidermal keratinocytes, SAA is reported to induce its own expression via TLR1/2 heterodimer. 12 We therefore investigated whether SAA could enhance the inflammatory responses in an autocrine/paracrine manner in dermal fibroblasts, and assessed expression of SAA in epidermal keratinocytes and dermal fibroblasts.
Methods Cell culture and stimuli
Normal human epidermal keratinocytes (NHEKs) were grown in serum-free medium (EpiLife) containing 0.06 mmol/L Ca 2+ and 19 growth supplement (EpiLife Defined Growth Supplement) at 37°C under standard tissue culture conditions. Normal human dermal fibroblasts (NHDFs) were grown in medium (Medium 106S) containing supplements (Low Serum Growth Supplements) (all cells and reagents from Invitrogen/ Cascade Biologics, Portland, OR, USA). Cultures were maintained for up to eight passages in these media with the addition of 100 U/mL penicillin, 100 lg/mL streptomycin and 0.25 lg/mL amphotericin B.
Cell stimulation
To investigate the effects of TLR ligands on the expression of SAA in NHEKs and NHDFs, cells were stimulated with Pam3CSK4 10 lg/mL, polyinosinic : polycytidylic acid (poly(I:C) 10 lg/mL, lipopolysaccharide (LPS) 10 lg/mL, flagellin 100 ng/mL, ODN M362 2 lmol/L (all InvivoGen, San Diego, CA, USA), macrophage-activating lipopeptide (MALP)-2, 100 ng/mL (Alexis Biochemicals, San Diego, CA, USA), or recombinant human SAA 10
À6 mol/L (PeproTech, Rocky Hill, NJ, USA) for 24 h. After cell stimulation, the total cell medium was stored at À20°C until analysis. RNA was extracted (TRIzol; Invitrogen, Carlsbad, CA, USA) after supernatant collection. RNA was stored at À80°C. 
Results
Toll-like receptor ligands induce expression of serum amyloid A in epidermal keratinocytes and dermal fibroblasts
Of our panel of TLR ligands, Pam3CSK4 (TLR1/2), poly (I:C) (TLR3), flagellin (TLR5), and MALP-2 (TLR2/6) significantly induced SAA expression at both the and protein synthesis levels in NHEKs (Fig. 1a,b) , while both Pam3CSK4 and MALP-2 significantly induced SAA expression in NHDFs (Fig. 1c,d ).
In the current study, knockdown of p65 (a subunit of NF-jB) by siRNA significantly suppressed the induction of SAA by Pam3CSK4, poly (I:C), flagellin, and MALP-2 in NHEKs (Fig. 2a,c) and also suppressed the induction of SAA by Pam3CSK4 and MALP-2 in NHDFs (Fig. 2b,d ).
Serum amyloid A induces its own expression through nuclear factor-jB in dermal fibroblasts SAA induced its own expression in NHDFs in a dosedependent manner (Fig. 3a) . As SAA is also reported to activate NF-jB signalling, 8, 20 we confirmed that the induction of SAA by SAA was significantly inhibited in NHDFs after knockdown of p65 (Fig. 3b) .
Serum amyloid A induces its own expression through Toll-like receptor 1/2 in dermal fibroblasts TLR1 and TLR2 siRNA significantly inhibited SAA induction by SAA in NHDFs (Fig. 4a-c) , and TLR1 and TLR2-neutralizing antibody also significantly inhibited induction of SAA by SAA in NHDFs (Fig. 4d) . These results suggest that SAA acts through the TLR1/2 heterodimer to induce the expression of SAA in dermal fibroblasts, as for epidermal keratinocytes.
Discussion
Previous studies have shown that TLR3 and TLR4 ligands induce SAA expression in airway epithelial cells and hepatocytes, respectively. 21, 22 In the present In NHDFs, among a panel of TLR ligands, TLR1/2 and 2/6 ligands induced SAA expression at both the transcript and protein synthesis levels. TLR5, TLR7 and TLR8 ligands were not evaluated in NHDFs, because these receptors were not constitutively detectable in cultured fibroblasts. SAA is one of the acute phage proteins and is considered to be synthesized mainly in the liver. 8, 13 We also demonstrated that the induction of SAA by TLR ligands in epidermal keratinocytes and dermal fibroblasts was NF-jBdependent, which is consistent with our previous report of SAA induction in keratinocytes. 12 The role of SAA in normal skin has not been fully elucidated as yet, but it is thought to contribute to innate immunity in the skin because it has the capacity to activate several types of cells, including neutrophils, monocytes and mast cells, and to induce inflammatory cytokines and chemokines. 8 We further demonstrated that SAA induces its own expression in NHDFs as previously reported for NHEKs, 12 suggesting that SAA can enhance inflammatory reactions in an autocrine/paracrine manner. Our results also showed that the induction of both SAA by SAA depends on NF-jB in NHDFs. TLR2, TLR4, CD36, RAGE and formyl peptide receptor-like (FPRL)1 have been reported tp be receptors for SAA. 8 Nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3 may also be involved in SAA signalling. 8 The findings of the present study indicate that TLR1/2 is, at least in part, involved in the induction of SAA by SAA in NHDFs.
Yamanaka et al. demonstrated that keratinocytespecific caspase-1 or mature IL-18 transgenic mice have elevated serum levels of SAA and dense amyloid deposition in the liver, kidney and spleen, 24 suggesting that persistent skin inflammation could trigger secondary amyloidosis. As IL-18 signalling is able to activate NF-jB, 25 epidermal keratinocytes and dermal at 80% confluency were stimulated with TLR ligands for 24 h. Relative SAA1/2 mRNA abundance was analysed by quantitative (q) PCR, and protein expression of SAA in the media was measured by ELISA. *P < 0.05, **P < 0.01, ***P < 0.001. Data are given as mean AE SEM of triplicate samples, and are representative of three independent experiments.
fibroblasts in the mice might continuously produce SAA via NF-jB.
Patients with RDEB have persistently higher serum levels of SAA. 19 They also have widespread persistent skin ulcers, and the keratinocytes and fibroblasts surrounding the ulcer lesions are continuously exposed to PAMPs and DAMPs. Therefore, elevation of SAA in the sera of patients with RDEB might be due to TLR-mediated SAA production by keratinocytes and fibroblasts in persistent, widespread skin ulcers. 
Conclusion
We have shown that TLR ligands induce expression of SAA via NF-jB in epidermal keratinocytes and dermal fibroblasts, and that SAA further induces its own expression via TLR1/2 and NF-jB in dermal fibroblasts. Our results provide new evidence that the skin's innate immune response contributes to the upregulation of SAA expression, and overproduction of SAA might increase the risk of systemic complications such as secondary amyloidosis in patients with RDEB.
What's already known about this topic?
• Epidermal keratinocytes and dermal fibroblasts express functional TLRs.
• SAA are produced mainly by hepatocytes but also a variety of cells, including immune cells, endothelial cells, synoviocytes and epidermal keratinocytes.
• SAA induces its own expression via TLR1/2 in epidermal keratinocytes.
What does this study add?
• TLR ligands induce SAA expression via NF-kB in epidermal keratinocytes and dermal fibroblasts.
• SAA induces its own expression via TLR1/2 in dermal fibroblasts. 
